Evidence map›Paper›PMID 24983626›Full record

ArticlePloS one2014

Bioluminescence imaging of Chlamydia muridarum ascending infection in mice.

Jessica Campbell, Yumeng Huang, Yuanjun Liu, Robert Schenken, Bernard Arulanandam, Guangming Zhong

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Impact of oralmSystems · 2025
    Article
  2. Immunization AgainstVaccines · 2025
    Article
  3. Development and Validation ofBio-protocol · 2025
    Article
  4. Diverse animal models forFrontiers in microbiology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Characterization of Pathogenic CD8Infection and immunity · 2022
    Article
  9. The hormonal environment and estrogen receptor signaling altersFrontiers in cellular and infection microbiology · 2022
    Article
  10. Article
  11. Gastrointestinal Chlamydia-Induced CD8Infection and immunity · 2021
    Article
  12. Infection and immunity · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica CampbellDepartment of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Yumeng HuangDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Yuanjun LiuDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Robert SchenkenDepartment of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Bernard ArulanandamDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas, United States of America.
Guangming ZhongDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.

Funding

MECHANISMS OF CHLAMYDIAL EVASION OF IMMUNE RECOGNATIONR01AI047997 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2000 to 2021
$6.9M
Chlamydia trachomatis proteomicsR01AI064537 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2005 to 2015
$3.5M
NIAID NIH HHS R01 AI047997NIAID NIH HHS R01AI047997NIAID NIH HHS R01 AI064537NIAID NIH HHS R01AI064537
6 · The paper itself

Abstract

Chlamydial pathogenicity in the upper genital tract relies on chlamydial ascending from the lower genital tract. To monitor chlamydial ascension, we engineered a luciferase-expressing C. muridarum. In cells infected with the luciferase-expressing C. muridarum, luciferase gene expression and enzymatic activity (measured as bioluminescence intensity) correlated well along the infection course, suggesting that bioluminescence can be used for monitoring chlamydial replication. Following an intravaginal inoculation with the luciferase-expressing C. muridarum, 8 of 10 mice displayed bioluminescence signal in the lower with 4 also in the upper genital tracts on day 3 after infection. By day 7, all 10 mice developed bioluminescence signal in the upper genital tracts. The bioluminescence signal was maintained in the upper genital tract in 6 and 2 mice by days 14 and 21, respectively. The bioluminescence signal was no longer detectable in any of the mice by day 28. The whole body imaging approach also revealed an unexpected airway infection following the intravaginal inoculation. Although the concomitant airway infection was transient and did not significantly alter the genital tract infection time courses, caution should be taken during data interpretation. The above observations have demonstrated that C. muridarum can not only achieve rapid ascending infection in the genital tract but also cause airway infection following a genital tract inoculation. These findings have laid a foundation for further optimizing the C. muridarum intravaginal infection murine model for understanding chlamydial pathogenic mechanisms.

Indexed as

Chlamydia muridarumMolecular ImagingAnimalsChlamydia InfectionsFemaleHeLa CellsHumansLuciferasesMiceMice, Inbred BALB CReproductive Tract InfectionsLuciferases

Identifiers

PMID24983626
PMCPMC4077820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.